Wells Fargo & Company »

Aptevo Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aptevo Therapeutics (APVO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptevo Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $6 33 0.19
2024-06-30 $0 33 0.00
2024-03-31 $168 36 4.67